Home Authors Posts by ME Staff

ME Staff

46820 POSTS 0 COMMENTS
Epizyme Celgene

Celgene Sees Opportunity in Epizyme, Should We?

ME Staff -
0
Gensight

IPO Watch: Novartis Majority Held GenSight; Hit or Miss?

ME Staff -
0
Novartis

What Entresto Means for Novartis

ME Staff -
0
Axovant

Is the Axovant IPO a Biotech Red Flag?

ME Staff -
0
Baxalta

Baxalta’s Pipeline Makes it an Interesting Opportunity in Biotech

ME Staff -
0
Juno Therapeutics

Celgene Values Juno at Twice Market Rate; Valid Upside Target?

ME Staff -
0
juno

As Good News Flows Out, Smart Money Flows into Juno Therapeutics

ME Staff -
0
Tekmira

Tekmira’s Ebola Drug Out Of the Race; Who’s Left in?

ME Staff -
0
Aerie Pharmaceuticals

Aerie Soars on FDA News: Here’s Why

ME Staff -
0
Redhill

Another Win for RedHill – What’s Next?

ME Staff -
0
1...4,6804,6814,682Page 4,681 of 4,682
/* */

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© Market Exclusive 2019
// AST – IMS - [MarketExclusive_ROS]